Lexology April 14, 2021
When negotiating a digital health collaboration agreement between a tech company and a life sciences company, whether for the development of artificial intelligence or other software, the provision of data hosting and analysis services, or a more complex collaboration, the parties should consider the following.
Business Culture Differences
How does each party negotiate deals? What is each party looking to get out of this relationship? Are there differences in the parties’ Food and Drug Administration (FDA) regulatory approaches and risk tolerance? Do the parties’ styles and goals align enough to get the deal done efficiently and work together? Differences in the parties’ cultures and specific business drivers to engage in the deal can impact negotiations and the parties’ working relationship...
Today's Sponsors
Today's Sponsor